

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte aggregation (GO:0070486) | 8.26202017 |
| 2 | activation of MAPKKK activity (GO:0000185) | 7.82169227 |
| 3 | DNA deamination (GO:0045006) | 6.55764154 |
| 4 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 5.98954194 |
| 5 | glycoprotein catabolic process (GO:0006516) | 5.12584655 |
| 6 | positive regulation of defense response to virus by host (GO:0002230) | 5.10772904 |
| 7 | rRNA transcription (GO:0009303) | 4.95550272 |
| 8 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 4.85234656 |
| 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.79499416 |
| 10 | iron-sulfur cluster assembly (GO:0016226) | 4.60445639 |
| 11 | metallo-sulfur cluster assembly (GO:0031163) | 4.60445639 |
| 12 | cytidine deamination (GO:0009972) | 4.40274914 |
| 13 | cytidine metabolic process (GO:0046087) | 4.40274914 |
| 14 | cytidine catabolic process (GO:0006216) | 4.40274914 |
| 15 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.31928914 |
| 16 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.20248762 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 3.99998886 |
| 18 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.97128335 |
| 19 | piRNA metabolic process (GO:0034587) | 3.95705921 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.95156113 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.75338540 |
| 22 | ATP synthesis coupled proton transport (GO:0015986) | 3.75338540 |
| 23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.68014938 |
| 24 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 3.63408315 |
| 25 | actin nucleation (GO:0045010) | 3.53195256 |
| 26 | protein-cofactor linkage (GO:0018065) | 3.51474376 |
| 27 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.51197648 |
| 28 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.51197648 |
| 29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.49644306 |
| 30 | induction of positive chemotaxis (GO:0050930) | 3.44536172 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32972836 |
| 32 | regulation of lymphocyte migration (GO:2000401) | 3.30723221 |
| 33 | regulation of activation of Janus kinase activity (GO:0010533) | 3.28034552 |
| 34 | indolalkylamine metabolic process (GO:0006586) | 3.26717743 |
| 35 | endoderm formation (GO:0001706) | 3.23185222 |
| 36 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.23026919 |
| 37 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.22164092 |
| 38 | positive regulation of cell killing (GO:0031343) | 3.18049278 |
| 39 | erythrocyte maturation (GO:0043249) | 3.17922785 |
| 40 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.15248206 |
| 41 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.14986079 |
| 42 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.14986079 |
| 43 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14698652 |
| 44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.13157035 |
| 45 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.12114962 |
| 46 | negative regulation of mast cell activation (GO:0033004) | 3.10338287 |
| 47 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.06628913 |
| 48 | regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516) | 3.02954269 |
| 49 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.00966538 |
| 50 | regulation of defense response to virus by host (GO:0050691) | 3.00874228 |
| 51 | DNA methylation involved in gamete generation (GO:0043046) | 2.99448338 |
| 52 | purine nucleotide salvage (GO:0032261) | 2.99013514 |
| 53 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.98259053 |
| 54 | regulation of cell killing (GO:0031341) | 2.87204403 |
| 55 | negative regulation by host of viral transcription (GO:0043922) | 2.86596214 |
| 56 | peroxisome fission (GO:0016559) | 2.86327997 |
| 57 | male meiosis I (GO:0007141) | 2.84990092 |
| 58 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.84361981 |
| 59 | NADH dehydrogenase complex assembly (GO:0010257) | 2.84361981 |
| 60 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.84361981 |
| 61 | hematopoietic stem cell differentiation (GO:0060218) | 2.84344722 |
| 62 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.76745761 |
| 63 | protein complex biogenesis (GO:0070271) | 2.75470399 |
| 64 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.74167198 |
| 65 | positive regulation of prostaglandin secretion (GO:0032308) | 2.73699664 |
| 66 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.73278401 |
| 67 | macroautophagy (GO:0016236) | 2.71746294 |
| 68 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.71331718 |
| 69 | termination of RNA polymerase III transcription (GO:0006386) | 2.71331718 |
| 70 | behavioral response to nicotine (GO:0035095) | 2.69848214 |
| 71 | respiratory electron transport chain (GO:0022904) | 2.67162181 |
| 72 | electron transport chain (GO:0022900) | 2.67058868 |
| 73 | sequestering of actin monomers (GO:0042989) | 2.63224389 |
| 74 | cytolysis (GO:0019835) | 2.61871066 |
| 75 | meiotic chromosome segregation (GO:0045132) | 2.60361249 |
| 76 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.59386636 |
| 77 | indole-containing compound catabolic process (GO:0042436) | 2.58166670 |
| 78 | indolalkylamine catabolic process (GO:0046218) | 2.58166670 |
| 79 | tryptophan catabolic process (GO:0006569) | 2.58166670 |
| 80 | L-fucose catabolic process (GO:0042355) | 2.57709912 |
| 81 | fucose catabolic process (GO:0019317) | 2.57709912 |
| 82 | L-fucose metabolic process (GO:0042354) | 2.57709912 |
| 83 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.56769217 |
| 84 | kynurenine metabolic process (GO:0070189) | 2.54412371 |
| 85 | spinal cord development (GO:0021510) | 2.53909528 |
| 86 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.53351340 |
| 87 | pseudouridine synthesis (GO:0001522) | 2.51669182 |
| 88 | cellular response to interleukin-15 (GO:0071350) | 2.51646138 |
| 89 | macrophage chemotaxis (GO:0048246) | 2.50791787 |
| 90 | resolution of meiotic recombination intermediates (GO:0000712) | 2.49949198 |
| 91 | positive regulation of vascular permeability (GO:0043117) | 2.49757288 |
| 92 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.48612766 |
| 93 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.48444911 |
| 94 | reciprocal DNA recombination (GO:0035825) | 2.48102210 |
| 95 | reciprocal meiotic recombination (GO:0007131) | 2.48102210 |
| 96 | proteasome assembly (GO:0043248) | 2.47813138 |
| 97 | hair cell differentiation (GO:0035315) | 2.44257599 |
| 98 | regulation of action potential (GO:0098900) | 2.43985424 |
| 99 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.42899712 |
| 100 | thrombin receptor signaling pathway (GO:0070493) | 2.42283104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.04172037 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.85353399 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.23644819 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.15028087 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87329371 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.87309739 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.74518762 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.51325123 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45756879 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.37552951 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.18718538 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15707969 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08231884 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.91740644 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90526955 |
| 16 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.85464389 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84448942 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73651436 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.73496395 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64985959 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62272240 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61265888 |
| 23 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.61073716 |
| 24 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.61073716 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.60738379 |
| 26 | AR_20517297_ChIP-Seq_VCAP_Human | 1.59520013 |
| 27 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.56421215 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54106748 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.52604047 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.48547849 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44554057 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43449139 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41847622 |
| 34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41509868 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39107220 |
| 36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38995959 |
| 37 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.37511219 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37315081 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36827471 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34776664 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34730324 |
| 42 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.31059620 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30957177 |
| 44 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30820681 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30357043 |
| 46 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.26636789 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.26359317 |
| 48 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24613937 |
| 49 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.23908326 |
| 50 | EWS_26573619_Chip-Seq_HEK293_Human | 1.23441072 |
| 51 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.22001781 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21782240 |
| 53 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.21644386 |
| 54 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.20539304 |
| 55 | ERA_21632823_ChIP-Seq_H3396_Human | 1.20451916 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19732674 |
| 57 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.19401850 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19257324 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.18417224 |
| 60 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.18054674 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17321761 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16125478 |
| 63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15145456 |
| 64 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.15057780 |
| 65 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13770420 |
| 66 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13770420 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12155805 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11717745 |
| 69 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.09924556 |
| 70 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09400308 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06482943 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05949629 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05907772 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.05814193 |
| 75 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.05538350 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.05386865 |
| 77 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04868277 |
| 78 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04836975 |
| 79 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.04627391 |
| 80 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.04436575 |
| 81 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.03992888 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03853537 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03849362 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03817003 |
| 85 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03472960 |
| 86 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03398689 |
| 87 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03151933 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02761663 |
| 89 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02420318 |
| 90 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.02244648 |
| 91 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01584425 |
| 92 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99637215 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99231347 |
| 94 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99053741 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97755325 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96385011 |
| 97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95691709 |
| 98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.94813460 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94808931 |
| 100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94808931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005623_abnormal_meninges_morphology | 6.45553115 |
| 2 | MP0005671_abnormal_response_to | 4.43259591 |
| 3 | MP0000750_abnormal_muscle_regeneration | 2.78721201 |
| 4 | MP0000013_abnormal_adipose_tissue | 2.66554073 |
| 5 | MP0003786_premature_aging | 2.42368147 |
| 6 | MP0009384_cardiac_valve_regurgitation | 2.40777737 |
| 7 | MP0005551_abnormal_eye_electrophysiolog | 2.33129185 |
| 8 | MP0002938_white_spotting | 2.14271830 |
| 9 | MP0004147_increased_porphyrin_level | 2.12588883 |
| 10 | MP0002102_abnormal_ear_morphology | 2.05426917 |
| 11 | MP0009785_altered_susceptibility_to | 1.95949597 |
| 12 | MP0002638_abnormal_pupillary_reflex | 1.91714721 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 1.85899440 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 1.84644975 |
| 15 | MP0002163_abnormal_gland_morphology | 1.78693262 |
| 16 | MP0001905_abnormal_dopamine_level | 1.77828851 |
| 17 | MP0006276_abnormal_autonomic_nervous | 1.76378657 |
| 18 | MP0001800_abnormal_humoral_immune | 1.69022845 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.64993293 |
| 20 | MP0002933_joint_inflammation | 1.61799866 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.60075623 |
| 22 | MP0002277_abnormal_respiratory_mucosa | 1.58841227 |
| 23 | MP0001501_abnormal_sleep_pattern | 1.51353216 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.50978590 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.48531772 |
| 26 | MP0006072_abnormal_retinal_apoptosis | 1.45133471 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.43152339 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.42572199 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.41754067 |
| 30 | MP0005387_immune_system_phenotype | 1.40454776 |
| 31 | MP0001790_abnormal_immune_system | 1.40454776 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.40414361 |
| 33 | MP0009745_abnormal_behavioral_response | 1.38807574 |
| 34 | MP0009379_abnormal_foot_pigmentation | 1.36164774 |
| 35 | MP0003195_calcinosis | 1.36083155 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.34975984 |
| 37 | MP0002723_abnormal_immune_serum | 1.34590639 |
| 38 | MP0009764_decreased_sensitivity_to | 1.34550999 |
| 39 | MP0004885_abnormal_endolymph | 1.33651487 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.33544824 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.31991026 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.31179778 |
| 43 | MP0001819_abnormal_immune_cell | 1.28682293 |
| 44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.28672409 |
| 45 | MP0000858_altered_metastatic_potential | 1.27324616 |
| 46 | MP0000685_abnormal_immune_system | 1.27273671 |
| 47 | MP0004947_skin_inflammation | 1.25470635 |
| 48 | MP0008872_abnormal_physiological_respon | 1.23931637 |
| 49 | MP0003011_delayed_dark_adaptation | 1.22474952 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.18449991 |
| 51 | MP0002272_abnormal_nervous_system | 1.17447659 |
| 52 | MP0003724_increased_susceptibility_to | 1.16477398 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.15356509 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.14068244 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.13896459 |
| 56 | MP0005025_abnormal_response_to | 1.13485952 |
| 57 | MP0009046_muscle_twitch | 1.12494543 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.11756014 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.09098392 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07726192 |
| 61 | MP0003880_abnormal_central_pattern | 1.07714711 |
| 62 | MP0003646_muscle_fatigue | 1.05463308 |
| 63 | MP0003866_abnormal_defecation | 1.04851440 |
| 64 | MP0006082_CNS_inflammation | 1.02054359 |
| 65 | MP0000762_abnormal_tongue_morphology | 1.00832176 |
| 66 | MP0005410_abnormal_fertilization | 0.96308054 |
| 67 | MP0002733_abnormal_thermal_nociception | 0.96058553 |
| 68 | MP0008877_abnormal_DNA_methylation | 0.93933480 |
| 69 | MP0002166_altered_tumor_susceptibility | 0.91939683 |
| 70 | MP0006292_abnormal_olfactory_placode | 0.90450309 |
| 71 | MP0003436_decreased_susceptibility_to | 0.89997225 |
| 72 | MP0001502_abnormal_circadian_rhythm | 0.88175296 |
| 73 | MP0001485_abnormal_pinna_reflex | 0.86987719 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 0.86893631 |
| 75 | MP0002064_seizures | 0.86828683 |
| 76 | MP0005195_abnormal_posterior_eye | 0.83345659 |
| 77 | MP0001486_abnormal_startle_reflex | 0.83095593 |
| 78 | MP0008770_decreased_survivor_rate | 0.82548516 |
| 79 | MP0002177_abnormal_outer_ear | 0.80645903 |
| 80 | MP0005389_reproductive_system_phenotype | 0.80461547 |
| 81 | MP0004742_abnormal_vestibular_system | 0.79652245 |
| 82 | MP0002736_abnormal_nociception_after | 0.79068035 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.77439954 |
| 84 | MP0003806_abnormal_nucleotide_metabolis | 0.77438281 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.77025666 |
| 86 | MP0001440_abnormal_grooming_behavior | 0.76274118 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.75814063 |
| 88 | MP0001970_abnormal_pain_threshold | 0.75487637 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.75283129 |
| 90 | MP0000716_abnormal_immune_system | 0.74396318 |
| 91 | MP0005253_abnormal_eye_physiology | 0.74258507 |
| 92 | MP0003787_abnormal_imprinting | 0.73957274 |
| 93 | MP0002006_tumorigenesis | 0.73718968 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.73519198 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.73247659 |
| 96 | MP0003879_abnormal_hair_cell | 0.73067758 |
| 97 | MP0002160_abnormal_reproductive_system | 0.72928028 |
| 98 | MP0004142_abnormal_muscle_tone | 0.71977325 |
| 99 | MP0004130_abnormal_muscle_cell | 0.71391201 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.70971897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebellar dysplasia (HP:0007033) | 8.85570146 |
| 2 | Type II lissencephaly (HP:0007260) | 8.83351664 |
| 3 | Retinal atrophy (HP:0001105) | 8.58555247 |
| 4 | Retinal dysplasia (HP:0007973) | 7.60947332 |
| 5 | Hypoplasia of the pons (HP:0012110) | 6.67488054 |
| 6 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 6.63612861 |
| 7 | Abnormality of the pons (HP:0007361) | 6.46856247 |
| 8 | Fatigue (HP:0012378) | 5.85654479 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 5.51894111 |
| 10 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.99989264 |
| 11 | IgG deficiency (HP:0004315) | 4.53966932 |
| 12 | Buphthalmos (HP:0000557) | 4.36773145 |
| 13 | Difficulty climbing stairs (HP:0003551) | 4.18420342 |
| 14 | Increased IgM level (HP:0003496) | 3.89424760 |
| 15 | Severe muscular hypotonia (HP:0006829) | 3.80732801 |
| 16 | Lissencephaly (HP:0001339) | 3.38730674 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05594012 |
| 18 | Entropion (HP:0000621) | 3.02299435 |
| 19 | Pachygyria (HP:0001302) | 2.90481996 |
| 20 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.89904749 |
| 21 | Megalocornea (HP:0000485) | 2.73070952 |
| 22 | Hypoplasia of the brainstem (HP:0002365) | 2.67968878 |
| 23 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.67968878 |
| 24 | Intellectual disability, profound (HP:0002187) | 2.67364949 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 2.65563502 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 2.65563502 |
| 27 | Pancreatic cysts (HP:0001737) | 2.58378123 |
| 28 | Mesangial abnormality (HP:0001966) | 2.51086228 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 2.51066792 |
| 30 | Pancreatic fibrosis (HP:0100732) | 2.50714530 |
| 31 | Generalized hypotonia (HP:0001290) | 2.43493335 |
| 32 | Abnormality of DNA repair (HP:0003254) | 2.42877581 |
| 33 | Abnormality of the vitreous humor (HP:0004327) | 2.42584526 |
| 34 | True hermaphroditism (HP:0010459) | 2.42490049 |
| 35 | Congenital stationary night blindness (HP:0007642) | 2.42090984 |
| 36 | Severe global developmental delay (HP:0011344) | 2.40824009 |
| 37 | Congenital glaucoma (HP:0001087) | 2.35928090 |
| 38 | Nephronophthisis (HP:0000090) | 2.26548355 |
| 39 | Papilledema (HP:0001085) | 2.26240353 |
| 40 | Non-midline cleft lip (HP:0100335) | 2.23140832 |
| 41 | Poikiloderma (HP:0001029) | 2.21754274 |
| 42 | Meningocele (HP:0002435) | 2.19899145 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.18110025 |
| 44 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.16360195 |
| 45 | Decreased subcutaneous fat (HP:0001002) | 2.14213877 |
| 46 | Erythroderma (HP:0001019) | 2.10778645 |
| 47 | Abnormal albumin level (HP:0012116) | 2.08104439 |
| 48 | Hypoalbuminemia (HP:0003073) | 2.08104439 |
| 49 | T lymphocytopenia (HP:0005403) | 2.07484007 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 2.07381223 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.05909698 |
| 52 | Generalized muscle weakness (HP:0003324) | 1.98542439 |
| 53 | Abnormal drinking behavior (HP:0030082) | 1.97774858 |
| 54 | Polydipsia (HP:0001959) | 1.97774858 |
| 55 | Fragile nails (HP:0001808) | 1.94708498 |
| 56 | Keratitis (HP:0000491) | 1.92081631 |
| 57 | Eosinophilia (HP:0001880) | 1.91074205 |
| 58 | Abnormality of vision evoked potentials (HP:0000649) | 1.90997926 |
| 59 | Abnormality of the renal medulla (HP:0100957) | 1.85544265 |
| 60 | Hypoproteinemia (HP:0003075) | 1.82578344 |
| 61 | Brittle hair (HP:0002299) | 1.82088363 |
| 62 | Stomatitis (HP:0010280) | 1.81899722 |
| 63 | Encephalitis (HP:0002383) | 1.80940181 |
| 64 | Hepatocellular necrosis (HP:0001404) | 1.78501448 |
| 65 | Abnormality of B cell number (HP:0010975) | 1.78441867 |
| 66 | Mitochondrial inheritance (HP:0001427) | 1.78247384 |
| 67 | Polyuria (HP:0000103) | 1.76323206 |
| 68 | Medial flaring of the eyebrow (HP:0010747) | 1.75937777 |
| 69 | Tubular atrophy (HP:0000092) | 1.75029402 |
| 70 | Attenuation of retinal blood vessels (HP:0007843) | 1.73691069 |
| 71 | Abnormality of eosinophils (HP:0001879) | 1.73632288 |
| 72 | Polymicrogyria (HP:0002126) | 1.73585150 |
| 73 | Asplenia (HP:0001746) | 1.72750062 |
| 74 | Aplastic anemia (HP:0001915) | 1.69932612 |
| 75 | Gowers sign (HP:0003391) | 1.69549143 |
| 76 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.69206019 |
| 77 | Keratoconus (HP:0000563) | 1.69067368 |
| 78 | Increased corneal curvature (HP:0100692) | 1.69067368 |
| 79 | CNS demyelination (HP:0007305) | 1.67498856 |
| 80 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.67101350 |
| 81 | Abnormality of T cells (HP:0002843) | 1.64725724 |
| 82 | Chronic hepatic failure (HP:0100626) | 1.64424189 |
| 83 | Acute necrotizing encephalopathy (HP:0006965) | 1.62423004 |
| 84 | Sclerocornea (HP:0000647) | 1.61453957 |
| 85 | Hepatic necrosis (HP:0002605) | 1.61301597 |
| 86 | Increased CSF lactate (HP:0002490) | 1.61198812 |
| 87 | Cerebral hypomyelination (HP:0006808) | 1.59920485 |
| 88 | Occipital encephalocele (HP:0002085) | 1.59874770 |
| 89 | Pallor (HP:0000980) | 1.59854394 |
| 90 | Decreased central vision (HP:0007663) | 1.59198434 |
| 91 | Dandy-Walker malformation (HP:0001305) | 1.57873216 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.57286745 |
| 93 | Muscular dystrophy (HP:0003560) | 1.55981951 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 1.55238273 |
| 95 | Holoprosencephaly (HP:0001360) | 1.53851546 |
| 96 | Pendular nystagmus (HP:0012043) | 1.53645166 |
| 97 | B lymphocytopenia (HP:0010976) | 1.53555095 |
| 98 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.53359751 |
| 99 | Conical tooth (HP:0000698) | 1.52900486 |
| 100 | Iris coloboma (HP:0000612) | 1.49910283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK10 | 5.41717207 |
| 2 | MARK3 | 5.35794037 |
| 3 | TLK1 | 4.08865684 |
| 4 | TXK | 3.83659017 |
| 5 | MAP4K2 | 2.72391309 |
| 6 | ADRBK2 | 2.70075638 |
| 7 | ZAK | 2.63024449 |
| 8 | KDR | 2.57700088 |
| 9 | PTK2B | 2.53165618 |
| 10 | BCKDK | 2.45666345 |
| 11 | FRK | 2.30763647 |
| 12 | PIM1 | 2.19041927 |
| 13 | TAOK3 | 1.99095816 |
| 14 | MAP4K1 | 1.77687361 |
| 15 | GRK1 | 1.71710185 |
| 16 | STK11 | 1.62274519 |
| 17 | WNK3 | 1.60121354 |
| 18 | TESK2 | 1.56229615 |
| 19 | TIE1 | 1.39088705 |
| 20 | TEC | 1.34442912 |
| 21 | SYK | 1.31249353 |
| 22 | VRK2 | 1.28186416 |
| 23 | ITK | 1.26986064 |
| 24 | PRKCH | 1.26800195 |
| 25 | VRK1 | 1.18511937 |
| 26 | MAP2K2 | 1.10723839 |
| 27 | LMTK2 | 1.09115138 |
| 28 | CDK19 | 1.05496350 |
| 29 | CAMKK2 | 1.01596337 |
| 30 | PIK3CA | 1.01449083 |
| 31 | MAP3K12 | 0.94250175 |
| 32 | GRK6 | 0.91912313 |
| 33 | RPS6KA4 | 0.89144436 |
| 34 | PINK1 | 0.86051163 |
| 35 | RPS6KA5 | 0.85600911 |
| 36 | IKBKB | 0.84011534 |
| 37 | NTRK2 | 0.83842742 |
| 38 | SIK2 | 0.83679005 |
| 39 | KIT | 0.83488477 |
| 40 | MAP3K4 | 0.81310859 |
| 41 | LCK | 0.81099881 |
| 42 | FES | 0.80332705 |
| 43 | NUAK1 | 0.79075746 |
| 44 | DAPK2 | 0.75270752 |
| 45 | PKN1 | 0.75022628 |
| 46 | PRKCQ | 0.73264293 |
| 47 | INSRR | 0.69665971 |
| 48 | DAPK1 | 0.68143325 |
| 49 | GRK7 | 0.67090594 |
| 50 | LYN | 0.65926232 |
| 51 | MAPK13 | 0.64709978 |
| 52 | DYRK2 | 0.64352769 |
| 53 | PHKG1 | 0.63780382 |
| 54 | PHKG2 | 0.63780382 |
| 55 | MAP2K6 | 0.63557536 |
| 56 | MAPKAPK5 | 0.63019891 |
| 57 | CSNK1G3 | 0.58757148 |
| 58 | ZAP70 | 0.57407510 |
| 59 | GRK5 | 0.57243021 |
| 60 | MAP3K11 | 0.57033908 |
| 61 | TSSK6 | 0.55567248 |
| 62 | CSNK1G2 | 0.55054115 |
| 63 | PRKCE | 0.53542097 |
| 64 | MARK1 | 0.53064319 |
| 65 | EIF2AK3 | 0.51710535 |
| 66 | BTK | 0.50228970 |
| 67 | MUSK | 0.48774036 |
| 68 | ADRBK1 | 0.47605071 |
| 69 | CLK1 | 0.47045845 |
| 70 | IGF1R | 0.45586978 |
| 71 | OBSCN | 0.45453936 |
| 72 | CAMK2A | 0.45233966 |
| 73 | CSNK1G1 | 0.43548936 |
| 74 | NME1 | 0.42740378 |
| 75 | EIF2AK2 | 0.40081977 |
| 76 | GSK3A | 0.39628086 |
| 77 | EPHA3 | 0.39399967 |
| 78 | DYRK1A | 0.38633470 |
| 79 | PRKACA | 0.38025520 |
| 80 | PRKCA | 0.37998016 |
| 81 | MAP2K7 | 0.35671698 |
| 82 | FYN | 0.35501755 |
| 83 | PRKCD | 0.35158306 |
| 84 | CSK | 0.34576282 |
| 85 | MST4 | 0.33911521 |
| 86 | OXSR1 | 0.33620336 |
| 87 | LIMK1 | 0.33380256 |
| 88 | CSNK1A1L | 0.33342440 |
| 89 | PLK3 | 0.32988089 |
| 90 | NLK | 0.31529147 |
| 91 | CASK | 0.31397806 |
| 92 | MAPKAPK3 | 0.30869422 |
| 93 | MINK1 | 0.29964872 |
| 94 | MAP3K5 | 0.29907274 |
| 95 | WNK4 | 0.29212853 |
| 96 | EPHA4 | 0.28471583 |
| 97 | MAPK11 | 0.27672946 |
| 98 | ERBB2 | 0.27560365 |
| 99 | CAMK1 | 0.26790322 |
| 100 | ABL1 | 0.26653288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.73051018 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.16974416 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.80348662 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.80314312 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.74769026 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.71111231 |
| 7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.67357544 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36050014 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35983890 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.28925788 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.28404995 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.24657497 |
| 13 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.17962496 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.10425229 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03636490 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.98545099 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.85999085 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.75884441 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70876831 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64717739 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57558998 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56738463 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55857778 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54749697 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.51912080 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51000106 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.44647201 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43292933 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42356296 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42194653 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.36764014 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30339365 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23502728 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17325783 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16300103 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12596139 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11062264 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06218801 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02520996 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01985243 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.01465988 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98485360 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91924133 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90035571 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89415091 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88296000 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 0.84461376 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83485533 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83131988 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82120729 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.81435905 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77740678 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75371605 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72875017 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72442418 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72133446 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71666239 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67963643 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66343008 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65258537 |
| 61 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64699920 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 0.64162489 |
| 63 | Purine metabolism_Homo sapiens_hsa00230 | 0.63734950 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63284122 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63218263 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60943220 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58272682 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57624423 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.57037525 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.53619473 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53190413 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50478885 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49716317 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49676771 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48934697 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47482046 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46500125 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46273337 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.44242319 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42017188 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38699376 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38648596 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38256344 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37612486 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37423530 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35157360 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33283330 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33045549 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.32958358 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31990008 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31832936 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31439223 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29675244 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29440521 |
| 95 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28352034 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27596062 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27534180 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.26877082 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.24630124 |
| 100 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.22956800 |

